Taysha Gene Therapies to Participate in Upcoming November Investor Healthcare Conferences

About this update from Taysha Gene Therapies, Inc.

[{"type":"text","content":"\nStifel 2021 Virtual Healthcare Conference on November 15, 2021 at 11:20 am ET\n\nJefferies London Healthcare Conference November 17, 2021 at 12:20 pm GMT\n\n4th Annual Evercore ISI HealthCONx Virtual Conference on November 30, 2021 at 4:20 pm ET\n\n DALLAS--(BUSINESS WIRE)--\nTaysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system (CNS) in both rare and large patient populations, today announced its participation in the Stifel 2021 Virtual Healthcare Conference, Jefferies London Healthcare Conference, and the 4th Annual Evercore ISI HealthCONx Virtual Conference.\n\n\n\nConference Details:\n\n\n\n\n\nEvent:\n\n\n\n \n\n\n\nStifel 2021 Virtual Healthcare Conference\n\n\n\n\n\nDate:\n\n\n\n \n\n\n\nNovember 15, 2021\n\n\n\n\n\nTime:\n\n\n\n \n\n\n\n11:20 am ET\n\n\n\n\n\nFormat:\n\n\n\n \n\n\n\nFireside Chat\n\n\n\n\n\nParticipants:\n\n\n\n \n\n\n\nRA Session II, President, Founder and Chief Executive Officer\n\n\n\n\n\n \n\n\n\n \n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n \n\n\n\n \n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n \n\n\n\n \n\n\n\nDr. Kimberly Lee, SVP, Corporate Communications and Investor Relations\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\nEvent:\n\n\n\n \n\n\n\nJefferies London Healthcare Conference\n\n\n\n\n\nDate:\n\n\n\n \n\n\n\nNovember 17, 2021\n\n\n\n\n\nTime:\n\n\n\n \n\n\n\n12:20 pm GMT\n\n\n\n\n\nFormat:\n\n\n\n \n\n\n\nFireside Chat\n\n\n\n\n\nParticipant:\n\n\n\n \n\n\n\nRA Session II, President, Founder and Chief Executive Officer\n\n\n\n\n\n \n\n\n\n \n\n\n\nDr. Suyash Prasad, Chief Medical Officer and Head of R&D\n\n\n\n\n\n \n\n\n\n \n\n\n\nKamran Alam, Chief Financial Officer\n\n\n\n\n\n \n\n\n\n \n\n\n\nDr. Kimberly Lee, SVP, Corporate Communications and Investor Relations\n\n\n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\nEvent:\n\n\n\n \n\n\n\n4th Annual Evercore ISI HealthCONx Virtual Conference\n\n\n\n\n\nDate:\n\n\n\n \n\n\n\nNovember 30, 2021\n\n\n\n\n\nTime:\n\n\n\n \n\n\n\n4:20 pm ET\n\n\n\n\n\nFormat:\n\n\n\n \n\n\n\nFireside Chat\n\n\n\n\n\nParticipant:\n\n\n\n \n\n\n\nRA Session II, President, Founder and Chief Executive Officer\n\n\n\n\n\n \n\n\n\n \n\n\n\nDr. Suyash Prasad,...

More updates from Taysha Gene Therapies, Inc.